Answers are grounded in this paper and cite their sources.
Background Substance use disorder populations in United Arab Emirates tertiary psychiatric services remain poorly characterized. We examined their clinical profile, pharmacotherapy, service utilization, care continuity, and temporal trends.Methods Retrospective cohort study of all patients with ICD-10 F10–F19 diagnoses at a tertiary psychiatric hospital in the United Arab Emirates, January 2018 to December 2025. Multivariable logistic regression examined factors associated with psychiatric comorbidity, and negative binomial regression assessed annual encounter trends.Results 5,489 patients, 89.5% male, contributed 31,859 encounters. Polysubstance/other presentations predominated (57.4%), and 49.9% had psychiatric comorbidity. Among patients with opioid dependence, 54.5% received opioid agonist therapy. Among alcohol-primary patients, 5.5% received naltrexone, the only guideline-concordant first-line agent in the hospital formulary. A facility-contact gap of at least 90 days occurred in 93.9% overall and 92.3% of patients with two or more clinical encounters. Encounter volume rose an average 19% annually (exploratory), peaking in 2023, most steeply for tobacco-related and opioid-related encounters.Conclusions In this single tertiary psychiatric hospital cohort, polysubstance presentations, dual diagnosis, pharmacotherapy gaps and interrupted facility contact were common. Prescribing shortfalls are documented at one facility and do not by themselves establish undertreatment. These findings provide a benchmark for comparable tertiary psychiatric services.
No takes yet. Share an insight, caveat, or question.
Bokhari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: